Quest PharmaTech Ltd. | Income Statement
Fiscal year is February-January. All values CAD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
-
-
-
2.60
38.90
7.50
Cost of Goods Sold (COGS) incl. D&A
43.00
37.50
31.80
16.10
29.70
7.50
Gross Income
43.00
37.50
31.80
13.50
9.20
7.50
SG&A Expense
2,050.70
2,619.90
2,177.20
4,303.30
7,803.10
9,034.40
EBIT
2,093.80
2,657.40
2,209.00
-
7,853.80
9,041.90
Unusual Expense
1,560.00
-
2,500.00
-
250.00
275
Non Operating Income/Expense
10.00
21.10
136.20
328.40
798.00
293.10
Interest Expense
97.80
103.40
133.10
-
-
-
Pretax Income
272.30
1,820.70
4,740.10
3,944.00
8,781.00
8,316.40
Equity in Affiliates
-
-
-
475.80
331.40
324.90
Consolidated Net Income
272.30
1,820.70
4,740.10
4,419.80
9,112.50
8,641.30
Net Income
272.30
1,820.70
4,632.90
2,460.20
5,086.20
4,358.80
Net Income After Extraordinaries
272.30
1,820.70
4,632.90
2,460.20
5,086.20
4,324.90
Net Income Available to Common
272.30
1,820.70
4,632.90
2,460.20
5,086.20
4,392.70
EPS (Basic)
0.00
0.02
0.04
0.02
0.03
0.03
Basic Shares Outstanding
86,590.70
104,149.70
122,660.00
150,422.60
159,343.40
167,182.90
EPS (Diluted)
0.00
0.02
0.04
0.02
0.03
0.03
Diluted Shares Outstanding
86,590.70
104,149.70
122,660.00
150,422.60
159,343.40
167,182.90
EBITDA
2,050.70
2,619.90
2,177.20
4,301.90
7,841.80
9,034.40
Other Operating Expense
-
-
-
-
59.90
-
Non-Operating Interest Income
369.20
961.20
238.20
44.50
120.80
157.40
Minority Interest Expense
-
-
107.20
1,959.50
4,026.20
4,282.60
About Quest PharmaTech
View Profile
